Syndax Pharmaceuticals Inc. (SNDX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 859 |
| % of all portfolios: | 0.005% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
4 |
$628,290 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Torray Funds |
0.38 |
Add 7.22% |
104,868 |
2,450,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 19 May 2025 |
GOLDAN KEITH A. |
Chief Financial Officer |
19 May 2025 |
3,000 |
0.00 |
0 |
| 19 May 2025 |
BOTWOOD NICHOLAS A.J. |
Head of R&D, CMO |
16 May 2025 |
11,765 |
8.99 |
105,826 |
| 19 May 2025 |
HUBER MARTIN H. JR. |
Director |
19 May 2025 |
5,000 |
8.99 |
44,950 |
| 19 May 2025 |
KATKIN KEITH |
Director |
19 May 2025 |
10,000 |
9.11 |
91,120 |
| 17 Jun 2024 |
GOLDAN KEITH A. |
Chief Financial Officer |
14 Jun 2024 |
1,250 |
20.03 |
25,037 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock